Geneial Receives Phase II SBIR Grant to Build Rare Disease Communities
Geneial is pleased to announce its award of a Phase II grant from the National Institutes of Health (NIH), specifically from the National Human Genome Research Institute (NHGRI). This signifies a significant milestone in our ongoing pursuit of advancing rare disease research and contributing to… Read More »Geneial Receives Phase II SBIR Grant to Build Rare Disease Communities